According to IMARC Group's latest research report, titled "Syphilis Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," presents a comprehensive analysis of the industry, covering syphilis testing market overview, statistics size, share, trends, demand, and growth prospects. The report also provides competitor and regional analysis and showcases the contemporary advancements in the global market.
The global syphilis testing market size reached US$ 1.15 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 1.63 Billion by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2023-2028.
Syphilis refers to a sexually transmitted infection (STI) that is caused by sexual intercourse and is passed by coming into touch with skin or mucous membranes. It initially appears as a painless sore on the mouth's rectum and genitalia. If neglected, it could lead to tertiary syphilis problems, which can harm the brain, nerves, blood vessels, and joints. Practitioners currently employ rapid plasma reagin (RPR) and the venereal diseases research laboratory (VDRL) as standard testing procedures that help in detecting early signs of syphilis. The rising awareness about STD treatment among the masses is providing an impetus to market growth.
Get Free Sample Copy of Report at – https://www.imarcgroup.com/syphilis-testing-market/requestsample
The global market is majorly driven by the rising prevalence of syphilis among the masses. Additionally, the ease of use and low-price points of syphilis test kits, which are readily available at online retail outlets and in-store pharmacies, are further fostering market expansion. Apart from this, the current research and development (R&D) operations to introduce efficient treatment alternatives and significant advancements in the healthcare industry are contributing to the market. Moreover, the development of the market is being aided by the favorable medical reimbursement rules that exist for the testing of STDs creating a positive market outlook. Some of the other factors driving the market include continual improvements in the healthcare infrastructure and rising investment in the development of medical facilities across the geographically extended locations.
The report has segmented the market into the following categories:
Type Insights:
Location of Testing Insights:
Breakup by Region:
Key Highlights of the Report:
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Who we are:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:
+91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
